Oscar Health (NYSE:OSCR) Price Target Raised to $26.00 at UBS Group

Oscar Health (NYSE:OSCR) had its price target increased by UBS Group from $20.00 to $26.00 in a report issued on Friday,Benzinga reports. The firm currently has a neutral rating on the stock.

A number of other brokerages have also recently issued reports on OSCR. Wolfe Research assumed coverage on Oscar Health in a report on Tuesday, May 5th. They set a “peer perform” rating on the stock. Wall Street Zen raised Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Barclays upped their price target on Oscar Health from $35.00 to $39.00 and gave the company an “overweight” rating in a research report on Thursday. Wells Fargo & Company set a $20.00 price target on shares of Oscar Health and gave the stock an “equal weight” rating in a report on Thursday, June 4th. Finally, Weiss Ratings upgraded shares of Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $24.00.

Oscar Health Stock Up 5.2%

Oscar Health stock opened at $27.93 on Friday. The firm has a 50 day simple moving average of $28.93 and a 200 day simple moving average of $20.37. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health has a 1-year low of $10.69 and a 1-year high of $33.10. The firm has a market capitalization of $8.42 billion, a price-to-earnings ratio of 19.95, a P/E/G ratio of 1.35 and a beta of 2.36.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. The firm had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a return on equity of 44.96% and a net margin of 3.60%.The business’s revenue for the quarter was up 70.4% on a year-over-year basis. During the same period last year, the company earned ($0.89) earnings per share. On average, analysts predict that Oscar Health will post 0.63 earnings per share for the current year.

Insider Activity

In other Oscar Health news, CFO Richard Scott Blackley sold 31,683 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $695,125.02. Following the completion of the sale, the chief financial officer owned 1,074,977 shares of the company’s stock, valued at $23,584,995.38. This represents a 2.86% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 147,500 shares of the company’s stock in a transaction that occurred on Tuesday, June 23rd. The stock was sold at an average price of $29.38, for a total value of $4,333,550.00. Following the completion of the sale, the director directly owned 1,360,866 shares of the company’s stock, valued at approximately $39,982,243.08. This represents a 9.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 3,662,466 shares of company stock valued at $105,145,815. 22.64% of the stock is owned by insiders.

Institutional Investors Weigh In On Oscar Health

A number of institutional investors have recently made changes to their positions in the business. Jones Financial Companies Lllp raised its position in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio purchased a new stake in Oscar Health during the first quarter valued at about $30,000. Fifth Third Bancorp boosted its position in Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after buying an additional 1,413 shares during the period. CoreCap Advisors LLC grew its stake in shares of Oscar Health by 526.3% during the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after buying an additional 1,000 shares during the last quarter. Finally, Quarry LP increased its holdings in shares of Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after buying an additional 1,469 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Key Headlines Impacting Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Substantial earnings and revenue beat: Oscar reported quarterly EPS of $1.10, versus the $0.40–$0.43 analyst consensus, compared with a $0.89 loss in the year-ago quarter. Revenue rose 70.4% to $4.88 billion, exceeding estimates of approximately $4.73 billion. Oscar Health Inc. Q2 Earnings Beat Estimates
• Positive Sentiment: Profitability improved sharply: The insurer generated approximately $361 million of second-quarter profit and more than $1 billion in net income during the first half, helped by membership growth and easing medical costs. Oscar Health Reports Another Big Profit
• Positive Sentiment: Full-year outlook was raised: Oscar increased its 2026 revenue forecast to $18.7 billion–$19.0 billion, above the roughly $18.6 billion consensus estimate, and indicated $500 million–$700 million in earnings from operations with an 81.5%–82.5% medical-loss-ratio target. Oscar Health Signals 2026 Earnings Outlook
• Neutral Sentiment: The results reinforce Oscar’s improving profit-turnaround story, with technology and operational execution remaining important to managing a changing customer base. Oscar Health 2026 Profit Turnaround
• Negative Sentiment: Churn outlook pressured the shares: Management’s forecast for elevated member churn raised concerns about retention, future enrollment growth and whether the unusually strong earnings can be sustained. That concern reportedly outweighed the quarterly beat and guidance increase. Oscar Health Falls as Churn Forecast Overshadows Q2 Beat

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.